FOXP3 and prostate cancer: Foxp3 was detected in epithelial cells of breast and prostate cancer patients, speculating that inhibition of Foxp3 expression in epithelial tumor cells may be a mechanism for tumors to escape immune surveillance (Chen et al., 2013; Lal et al., 2013).